Also found in: Medical, Encyclopedia.


 (mī′ə-lŏj′ə-nəs) also my·e·lo·gen·ic (-lə-jĕn′ĭk)
Originating in or produced by the bone marrow.


(ˌmaɪ əˈlɒdʒ ə nəs)

also my•e•lo•gen•ic

(-ləˈdʒɛn ɪk)
produced in the bone marrow.


, myelogenous
a. mielógeno-a, que se produce en la médula.
References in periodicals archive ?
Included in this trial are patients with acute myelogenous leukemia (AML), non-Hodgkin's lymphoma (NHL).
Summary: Chronic Myelogenous Leukemia (CML) takes place when the bone marrow starts making too many white blood cells.
[USPRwire, Thu Feb 28 2019] A new report titled " Chronic Myelogenous Leukaemia Treatment Market Industry Development Scenario and Forecast to 2026 " has been included in the enormous research repository of Market Research Reports Search Engine (MRRSE) that compiles various facets of the Chronic Myelogenous Leukaemia Treatment Market at a global level portraying a holistic analysis of the marketplace along with intelligence on key participants.
Alexander Hoischen, PhD, from Radboud University Medical Center in the Netherlands, will provide an update on their study comparing Bionano optical mapping with Saphyr to the current clinical testing workflows for Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia among other hematologic malignancies and some genetic disorders.
8, 2008, Francis was diagnosed with acute myelogenous leukemia (AML), which is a type of cancer in the blood and bone marrow.
Busulfan is used in combination with cyclophosphamide in the treatment of chronic myelogenous leukemia.
Chronic Myelogenous Leukemia (CML) usually presents in chronic phase, followed by an accelerated phase and a blast phase, if untreated.
Haematopoietic anomalies that were found to be associated with Turner are Iron deficiency anaemia, congenital erythroid hyperplasia, acute lymphoblastic leukaemia, acute myelogenous leukaemia and PH-positive chronic myelogenous leukaemia.3-6 We are reporting a case of Acute Myelogenous Leukaemia M2 (Acute Myelogenous leukaemia with maturation) associated with Turner Syndrome.
Philadelphia chromosome is found in most patients with chronic myelogenous leukemia (CML) and sometimes also in acute lymphoblastic leukemia and acute myelogenous leukemia.
Prior to that, he was responsible for teams at BMS that advanced more than 20 compounds into clinical development including SPRYCEL (dasatinib) for the treatment of chronic myelogenous leukemia, which he co-invented.